NFKB1 and non-small cell lung carcinoma: SUMO1 overexpression in Non-small cell lung cancer (NSCLC) is linked to a more aggressive tumor phenotype and poorer prognosis, likely through its promotion of NF-κB activity and subsequent regulation of genes involved in tumor cell proliferation, invasion, and metastasis(Ke et al. 2019).